Back to Search
Start Over
Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in rats.: LPC aggravates liver CCl4-induced fibrosis
- Source :
- Laboratory Investigation, Laboratory Investigation, Nature Publishing Group, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩, Laboratory Investigation, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩
- Publication Year :
- 2012
- Publisher :
- HAL CCSD, 2012.
-
Abstract
- International audience; Hepatic fibrosis, the major complication of virtually all types of chronic liver damage, usually begins in portal areas, and its severity has been correlated to liver progenitor cells (LPC) expansion from periportal areas, even if the primary targets of injury are intralobular hepatocytes. The aim of this study was to determine the potential fibrogenic role of LPC, using a new experimental model in which rat liver fibrosis was induced by chronic carbon tetrachloride (CCl(4)) administration for 6 weeks, in combination with chronic acetylaminofluorene treatment (AAF), which promotes activation of LPC compartment. Treatment with CCl(4) alone caused a significant increase in serum transaminase activity as well as liver fibrosis initiating around central veins and leading to formation of incomplete centro-central septa with sparse fibrogenic cells expressing α-smooth muscle actin (αSMA). In AAF/CCl(4)-treated animals, the fibrogenic response was profoundly worsened, with formation of multiple porto-central bridging septa leading to cirrhosis, whereas hepatocellular necrosis and inflammation were similar to those observed in CCl(4)-treated animals. Enhanced fibrosis in AAF/CCl(4) group was accompanied by ductule forming LPC expanding from portal areas, αSMA-positive cells accumulation in the fibrotic areas and increased expression of hepatic collagen type 1, 3 and 4 mRNA. Moreover, CK19-positive LPC expressed the most potent fibrogenic cytokine transforming growth factor-β (TGFβ) without any expression of αSMA, desmin or fibroblast-specific protein-1, demonstrating that LPC did not undergo an epithelial-mesenchymal transition. In this new experimental model, LPC, by expressing TGFβ, contributed to the accumulation of αSMA-positive myofibroblasts in the ductular reaction leading to enhanced fibrosis but also to disease progression and to a fibrotic pattern similar to that observed in humans.
- Subjects :
- Male
Pathology
medicine.medical_specialty
Cirrhosis
Epithelial-Mesenchymal Transition
medicine.medical_treatment
Antigens, Differentiation, Myelomonocytic
Inflammation
Liver Cirrhosis, Experimental
Article
Pathology and Forensic Medicine
Rats, Sprague-Dawley
03 medical and health sciences
TGFβ
0302 clinical medicine
Fibrosis
Antigens, CD
Transforming Growth Factor beta
Acetylaminofluorene
medicine
Animals
[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology
epithelial-mesenchymal transition
Molecular Biology
Carbon Tetrachloride
030304 developmental biology
Keratin-19
0303 health sciences
biology
Stem Cells
fibrosis
liver progenitor cells
Cell Biology
Transforming growth factor beta
2-Acetylaminofluorene
medicine.disease
Actins
3. Good health
Rats
Cytokine
Liver
biology.protein
030211 gastroenterology & hepatology
medicine.symptom
Hepatic fibrosis
Transforming growth factor
Subjects
Details
- Language :
- English
- ISSN :
- 00236837 and 15300307
- Database :
- OpenAIRE
- Journal :
- Laboratory Investigation, Laboratory Investigation, Nature Publishing Group, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩, Laboratory Investigation, 2012, 92 (1), pp.135-50. ⟨10.1038/labinvest.2011.143⟩
- Accession number :
- edsair.doi.dedup.....bcf54c1eb7cb77bba688c4a3db6ce7a5
- Full Text :
- https://doi.org/10.1038/labinvest.2011.143⟩